QCI Interpret for Oncology

The Implementation Journey of Comprehensive Cancer Genome Profiling and Liquid Biopsy in South East Asia

161 views
August 16, 2024
This session traces the evolution of comprehensive cancer genome profiling (CGP) and liquid biopsy techniques in South East Asia, discussing the initial hurdles and ultimate triumphs. It details how interventions like international collaborations, technological enhancements, and policy support have enabled these advanced diagnostic tools' successful adoption. Highlighting the critical role of liquid biopsy in early cancer detection and monitoring treatment efficacy, the study underscores the importance of continued genomics research and investment for improved cancer care globally. It illustrates that, despite significant challenges, integrating advanced genomic profiling into oncology practice is attainable and transformative.

Related videos

QCI Interpret for Oncology

Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...

426 views October 31, 2023

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...

QCI Interpret for Oncology

Clinician’s Roundtable: Interpreting genomic test results for precision oncology

390 views May 21, 2024

You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event...

QCI Interpret for Oncology

Comprehensive Molecular Tumor Analysis with Alacris Theranostics

357 views March 09, 2023

Precision oncology approaches have made great strides harnessing individual...

QCI Interpret for Oncology

Agilent Alissa to QCI Interpret: How can your lab reduce the stress and complexity of...

328 views March 26, 2024

In 2023, Agilent announced the discontinuation of their Alissa Interpret...